ADBiotech Co., Ltd. (KOSDAQ:179530)

ADBiotech Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 15, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	50,085	33,212	19,012	29,935	30,712	45,092
Market Cap Growth	154.42%	74.69%	-36.49%	-2.53%	-31.89%	20.26%
Enterprise Value	55,471	32,727	27,330	39,459	35,183	-
Last Close Price	2545.00	2030.00	2080.00	3275.00	3360.00	9100.00
PE Ratio	-	-	-	-	11.39	-
PS Ratio	3.88	2.58	1.71	2.86	2.89	3.81
PB Ratio	3.26	2.16	3.99	2.38	1.90	8.83
P/TBV Ratio	3.28	2.17	5.88	2.66	1.90	8.84
P/FCF Ratio	-	-	-	398.99	-	-
P/OCF Ratio	-	-	-	95.05	-	-
EV/Sales Ratio	4.30	2.54	2.45	3.77	3.31	-
EV/FCF Ratio	-3.24	-	-	525.92	-	-
Debt / Equity Ratio	1.09	1.09	2.51	1.08	0.79	2.58
Debt / FCF Ratio	-	-	-	181.40	-	-
Net Debt / Equity Ratio	0.35	0.35	2.16	0.33	0.26	2.04
Net Debt / EBITDA Ratio	-2.10	-2.10	-3.33	-1.15	-0.97	-11.50
Net Debt / FCF Ratio	-0.31	-0.31	-2.40	55.93	-0.44	-1.81
Asset Turnover	0.36	0.36	0.44	0.35	0.41	0.60
Inventory Turnover	3.32	3.32	3.07	2.78	2.97	3.52
Quick Ratio	0.46	0.46	0.35	0.98	0.89	0.50
Current Ratio	0.70	0.70	0.62	1.19	1.20	0.69
Return on Equity (ROE)	-33.04%	-33.04%	-103.66%	-37.78%	25.33%	-36.92%
Return on Assets (ROA)	-6.12%	-6.12%	-10.06%	-10.09%	-11.98%	-4.88%
Return on Capital Employed (ROCE)	-18.70%	-18.70%	-43.00%	-28.40%	-25.90%	-18.70%
Earnings Yield	-6.60%	-9.95%	-41.83%	-9.57%	8.78%	-5.91%
FCF Yield	-34.20%	-51.58%	-22.54%	0.25%	-30.34%	-12.74%
Buyback Yield / Dilution	-31.45%	-31.40%	0.00%	9.33%	-31.17%	-53.77%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.